Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Jarrell, Noble (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S555000
Reexamination Certificate
active
07968540
ABSTRACT:
Compounds of formula I:(wherein variables A1, A2, A3, A4, A5, A6, A7, B1, B2, B3, B4, D1, D2, E1, E2, E3, E4, E5, G1, G2, R6, T, U, V, W, X, Y and Z are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 5436261 (1995-07-01), Cordi et al.
patent: 6548710 (2003-04-01), Woudenberg
patent: 7189722 (2007-03-01), Bell et al.
patent: 7192954 (2007-03-01), Bell et al.
patent: 7202251 (2007-04-01), Bell et al.
patent: 7384930 (2008-06-01), Chaturvedula et al.
patent: 7384931 (2008-06-01), Chaturvedula et al.
patent: WO 2004/082605 (2004-09-01), None
patent: WO 2004/082605 (2004-09-01), None
patent: WO 2004/087649 (2004-10-01), None
patent: WO 2006/029153 (2006-03-01), None
patent: WO 2006/031491 (2006-03-01), None
patent: WO 2006/031513 (2006-03-01), None
patent: WO 2006/031606 (2006-03-01), None
patent: WO 2006/031610 (2006-03-01), None
patent: WO 2006/031676 (2006-03-01), None
patent: WO 2006/052378 (2006-05-01), None
patent: WO 2007/061676 (2007-05-01), None
patent: WO 2007/061677 (2007-05-01), None
patent: WO 2007/061692 (2007-05-01), None
patent: WO 2007/061695 (2007-05-01), None
patent: WO 2007/061696 (2007-05-01), None
Supplementary European Search Report and Search Opinion for counterpart European patent application No. EP 06 82 7801, Aug. 23, 2010.
Bell Ian M.
Gallicchio Steven N.
Stump Craig A.
Theberge Cory R.
Zartman C. Blair
Devlin Bernard
Jarrell Noble
Merck Sharp & Dohme Corp.
Yuro Raynard
LandOfFree
Spirohydantoin tricyclic CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirohydantoin tricyclic CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirohydantoin tricyclic CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2697029